Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility – malaria (AMFm) program will be available in select countries “in two week’s time,” SABC News reports. The announcement came Monday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya.
Global Fund Approves ‘In Principle’ $47M Grant For Reducing Spread Of HIV Among MSM, Transgender In South Asia
The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved, “in principle,” a $47 million grant to reduce the spread of HIV among gay and other men who have sex with men in seven south Asian countries, IANS/Thaindian.com reports.
The Kaiser Family Foundation (KFF) on Wednesday “held a live, interactive webcast to examine recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria and the implications for U.S. global health policy,” the foundation reports on its webpage, where a video recording of the webcast is available. “A panel of experts discussed the Global Fund’s recent funding challenges and reorganization, how the U.S. and other donor nations are responding to these changes, and the future outlook for the Fund’s efforts to address HIV, TB, and malaria around the world,” KFF notes (6/13).
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 4 of its newsletter, the “Global Fund News Flash.” The issue features a commentary by Mireille Guigaz, a Global Fund Board member representing France, on the Global Fund’s work in Madagascar, and a piece examining “a Board decision last November that 55 percent of all funding for grant renewals should go to low-income countries,” among other stories (6/19).
Aidspan, an independent watchdog of the Global Fund, on Tuesday published Issue 187 of its “Global Fund Observer.” The issue includes an article on an Office of the Inspector General (OIG) report on its audit of eight Global Fund grants in Kenya; an article examining how reprogramming existing grants can improve their impact; and commentary from Bernard Rivers, executive director of Aidspan, about the Round 2 grants in Kenya (6/5).
The Center for Global Health Policy’s “Science Speaks” blog profiles Bernard Rivers, founder and executive director of Aidspan, a watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, who is leaving his position after 10 years. “He will not be running Aidspan anymore, but plans to continue to research and write about Global Fund issues,” the blog states. In the blog, Rivers discusses his motivation behind founding Aidspan and his hopes for the future of the Global Fund (Barton, 8/30).
After announcing it plans to spend an additional $1.67 million over the next two years, the Global Fund to Fight AIDS, Tuberculosis and Malaria Board on Friday at the end of its 26th meeting in Geneva said (.pdf) its “secretariat will present at an upcoming board meeting in September new funding models drafted in consultation with recipient countries and other stakeholders,” and the board will “announce funding decisions no later than April 2013,” Devex reports.
Al Jazeera’s “Counting the Cost” program on Saturday focused on the fight against malaria and the “business behind its treatment and prevention.” According to the program, progress against malaria “is being threatened in these tough economic times. There is a $3 billion shortfall in funding for malaria treatment and prevention.” The program reports on drug-resistant malaria strains in South-East Asia; examines a vaccine candidate under development by GlaxoSmithKline; speaks with Jo Lines of the London School of Hygiene and Tropical Medicine and Christoph Benn of the Global Fund to Fight AIDS, Tuberculosis and Malaria about the impact of the international financial crisis on the fight against the disease; and discusses a mobile phone app developed by a group of medical students that would help people receive a quicker diagnosis and treatment (Santamaria, 5/26).
In a report released last week, Members of Parliament (MPs) on the International Development Committee urged the U.K. to increase its donation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, according to a Committee press release (5/22). “Ministers have said they will increase the commitment, but the MPs are concerned that this money” — pledged by ministers over a year ago — “has not yet been delivered, nor the amount of the increase confirmed,” BBC News writes (Dreaper, 5/22).
Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center’s “Global Health Policy” blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria “might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back,” but “with the current poor status of basic information on beneficiaries and costs, it’s difficult to judge whether these cuts are good or bad.” They outline the history of AIDS funding in Ethiopia, posit what future funding might encompass, and say additional information is needed from PEPFAR, the Global Fund, and the Ethiopian government in order to know the true impacts of reduced funding (9/11).